Category
Primary
pharmaceutical-drugs · embed-ft 0.4
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Also (top-3)
Tech stack
CDN
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
Arog Pharmaceuticals — Advancing Crenolanib for High-Risk AML
Description
Arog Pharmaceuticals is advancing crenolanib, a potent type I pan-FLT3 inhibitor, for post-HSCT maintenance in high-risk AML patients with FLT3-ITD and NPM1 mutations. Phase III-ready.
Final URL
Language
en (html)
Scanned at
2026-06-18 22:23:50